CompoAtlas

Meiziya Kang CQ20 Capsules

Meiziya Kang CQ20 Capsules : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Monascus purpureusMonascus purpureus[333 mg,450 mg]Not identified
Glycine maxGlycine max[50 mg,450 mg]Not identified
Salvia miltiorrhizaSalvia miltiorrhiza[67 mg,450 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL20086102T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
MEIZIYA INTERNATIONAL SDN. BHD.
Manufacturer
WAN YEEN TRADING SDN. BHD.
Registration period starting
2025-08-22
Published validity end
2030-08-22

Original register data

View published fields and their variants
Active ingredients
Monascus purpureus[333 mg,450 mg],Glycine max[50 mg,450 mg],Salvia miltiorrhiza[67 mg,450 mg]
Valid until
2030-08-22
Registration date
2025-08-22
Published description
NATURAL PRODUCT
Licence holder
MEIZIYA INTERNATIONAL SDN. BHD.
Producer
WAN YEEN TRADING SDN. BHD.
Published name
Meiziya Kang CQ20 Capsules
Published reference
202002203461T
Registration number
MAL20086102T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20086102T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycine max
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Meiziya Kang CQ20 Capsules”, https://compoatlas.com/en/supplements/malaysia/MAL20086102T-meiziya-kang-cq20-capsules, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line